Thermo Fisher Scientific has agreed to acquire Olink Holding, an Uppsala, Sweden-based company focused on research platforms, for $3.1 billion. 

Olink offers solutions for proteomics discovery and development, and its proprietary technology, Proximity Extension Assay (PEA), provides protein analysis for the very large installed base of qPCR and next-generation sequencing readout systems in the market. 

Under the agreement, Thermo Fisher will pay $26.00 per common share in cash, for a total of $3.1 billion. The transaction is subject to customary closing conditions, including receipt of applicable regulatory approvals, and completion of the tender offer. The acquisition is expected to close in mid 2024. 

Source: Thermo Fisher Scientific